These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18205045)

  • 1. Exploring and validating surrogate endpoints in colorectal cancer.
    Burzykowski T; Buyse M; Yothers G; Sakamoto J; Sargent D
    Lifetime Data Anal; 2008 Mar; 14(1):54-64. PubMed ID: 18205045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review.
    Savina M; Gourgou S; Italiano A; Dinart D; Rondeau V; Penel N; Mathoulin-Pelissier S; Bellera C
    Crit Rev Oncol Hematol; 2018 Mar; 123():21-41. PubMed ID: 29482777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials.
    Nie RC; Zou XB; Yuan SQ; Chen YB; Chen S; Chen YM; Chen GM; Chen XJ; Luo TQ; Li SM; Duan JL; Wang Y; Li YF
    BMC Cancer; 2020 May; 20(1):421. PubMed ID: 32410591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.
    Sharma R; Beith J; Hamilton A
    Breast; 2005 Jun; 14(3):181-91. PubMed ID: 15927827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual- and trial-level surrogacy in colorectal cancer.
    Buyse M; Burzykowski T; Michiels S; Carroll K
    Stat Methods Med Res; 2008 Oct; 17(5):467-75. PubMed ID: 18285439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer.
    Elia EG; Städler N; Ciani O; Taylor RS; Bujkiewicz S
    Cancer Epidemiol; 2020 Feb; 64():101665. PubMed ID: 31911395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.
    Burzykowski T; Buyse M
    Pharm Stat; 2006; 5(3):173-86. PubMed ID: 17080751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two simple approaches for validating a binary surrogate endpoint using data from multiple trials.
    Baker SG
    Stat Methods Med Res; 2008 Oct; 17(5):505-14. PubMed ID: 18285436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials.
    Petrelli F; Tomasello G; Ghidini M; Lonati V; Passalacqua R; Barni S
    HPB (Oxford); 2017 Nov; 19(11):944-950. PubMed ID: 28764887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surrogate endpoints for overall survival in lung cancer trials: a review.
    Fiteni F; Westeel V; Bonnetain F
    Expert Rev Anticancer Ther; 2017 May; 17(5):447-454. PubMed ID: 28399678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.
    Sargent DJ; Patiyil S; Yothers G; Haller DG; Gray R; Benedetti J; Buyse M; Labianca R; Seitz JF; O'Callaghan CJ; Francini G; Grothey A; O'Connell M; Catalano PJ; Kerr D; Green E; Wieand HS; Goldberg RM; de Gramont A;
    J Clin Oncol; 2007 Oct; 25(29):4569-74. PubMed ID: 17876008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspective.
    Grothey A
    Stat Methods Med Res; 2008 Oct; 17(5):529-35. PubMed ID: 18285442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of surrogate end points for overall survival in advanced colorectal cancer: further need for clarification: Letter to the editor on: Ciani et al., 2015, Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. 2015, J Clin Epidemiol 68:833-842.
    Schürmann C; Wieseler B
    J Clin Epidemiol; 2016 Feb; 70():278-9. PubMed ID: 26348800
    [No Abstract]   [Full Text] [Related]  

  • 15. How to use frailtypack for validating failure-time surrogate endpoints using individual patient data from meta-analyses of randomized controlled trials.
    Sofeu CL; Rondeau V
    PLoS One; 2020; 15(1):e0228098. PubMed ID: 31990928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
    Harshman LC; Xie W; Moreira RB; Bossé D; Ruiz Ares GJ; Sweeney CJ; Choueiri TK
    Cancer; 2018 Mar; 124(5):925-933. PubMed ID: 29266178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature.
    Saad ED; Katz A; Hoff PM; Buyse M
    Ann Oncol; 2010 Jan; 21(1):7-12. PubMed ID: 19901012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials.
    Chen YP; Sun Y; Chen L; Mao YP; Tang LL; Li WF; Liu X; Zhang WN; Zhou GQ; Guo R; Lin AH; Ma J
    Radiother Oncol; 2015 Aug; 116(2):157-66. PubMed ID: 26243677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate endpoints for overall survival in advanced colorectal cancer: a clinician's perspective.
    Piedbois P; Miller Croswell J
    Stat Methods Med Res; 2008 Oct; 17(5):519-27. PubMed ID: 18285441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.